Tranding
Hap2py Launches in Thailand, Uniting Profit with Purpose
Abracon Names Brian Holt Vice President of Global Sales
Possibilities and Opportunities: Seminar held in Hong Kong about ETF Connect in China Allocation
enreap becomes an official Atlassian Specialized Partner in ITSM
China's Miao embroidery dresses shine at Milan Fashion Week
2024-11-22 22:05:59

CUSMail

OTC/SmallCap IRW

Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Chronic Graft Versus Host Disease (cG
Corporate/ 2023-07-23
Mallinckrodt and Terumo Blood and Cell T...

– In a dual-review process,two independent advisory committees to the Australian Minister for Health recommended reimbursement based on a f...

BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine
Corporate/ 2023-07-23
BioVaxys Files US Patent Application for...

VANCOUVER,BC,Oct. 20,2021-- BioVaxys Technology Corp. (CSE: BIOV),(FRA:5LB),(OTCQB:BVAXF) ("BioVaxys" or "Company"),anno...

Corporate / 2023-07-23
Roan Holdings Group Announces Agreement to Set U...
Corporate / 2023-07-23
Roan Holdings Group Announces Agreement to Set U...
Corporate / 2023-07-23
Emmaus Life Sciences Acquires Key Intellectual P...
Corporate / 2023-07-23
Integrated Media Technology Limited Enters US$11...
Corporate / 2023-07-23
Kazia Therapeutics to Present at LD Micro Main E...
Corporate / 2023-07-23
NanoViricides Provides Update on Its Pan-Coronav...
Corporate / 2023-07-23
BioVaxys Begins Toxicity Study Ahead of CoviDTH ...
Corporate / 2023-07-23
Significantly Improved Safety Profile and Metabo...
Corporate / 2023-07-23
BioVaxys Prepares for Groundbreaking Study on re...
Corporate / 2023-07-23
Bionomics Prepares BNC210 for Start of Phase 2 A...
Corporate / 2023-07-23
BioVaxys Cancer Vaccine Manufacturing Partner Bi...
Corporate / 2023-07-23
BioVaxys Bioproduction Partner WuXi Biologics Co...
Corporate / 2023-07-23
RedHill Biopharma Accelerates Ongoing U.S. Phase...
Corporate / 2023-07-23
The Valens Company Achieves Access to GMP Manufa...
Corporate / 2023-07-23
NeuExcell Therapeutics and Spark Therapeutics An...
Corporate / 2023-07-23
Ethics Approval Granted for Clinical Trial of Wo...
Corporate / 2023-07-23
Further Study in humans shows that the DTH respo...
Corporate / 2023-07-23
Roan Holdings Group Co., Ltd. Announces New Mana...

Follow Us

12,345 Fans 12,345 Followers
12,345 Connects 12,345 Followers
12,345 Subscribers 12,345 Followers

Newsletter

Join us to get the latest news.

Received instesting content ASAP

Tranding

News / 2023-11-05
Hap2py Launches in Thailand, Uniting Profit with Purpose
News / 2023-11-05
Abracon Names Brian Holt Vice President of Global Sales
News / 2023-11-05
Possibilities and Opportunities: Seminar held in Hong Ko
News / 2023-11-05
enreap becomes an official Atlassian Specialized Partner
Exhibition / 2023-09-26
China's Miao embroidery dresses shine at Milan Fash

Tags

Computer/ElectronicsBanking/Financial ServiceHealth Care/HospitalTelecommunicationsComputer SoftwareMedical/PharmaceuticalsEntertainmentRetailTransportationEnvironmental Products & Services

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

Categories

NewsBusinessGeneral BusinessFinancial ServicesExhibitionReal Estate and FurnitureAdvertising, Marketing MediaPolicy & Public InterestTechnologyAuto & TransportationBusiness TechnologyConsumer TechnologyEnergyEnvironmentTelecommunicationsHeavy Industry & ManufacturingCorporateEntertainmentLifeStyleTravelFoodsHealthSportsEducation

Tags

Fitness/WellnessArtificial IntelligenceSupply Chain/LogisticsGeneral ManufacturingCloud Computing / Internet of ThingsEnvironmentVoIPMutual FundsCannabisInfectious Disease ControlOTC/SmallCap IRWPublic InterestTobaccoBridal ServicesLegal Services

Quick Links

AboutAdvertisePrivacy & policyTerms & conditionsContact

© CUSMAIL. All Rights Reserved. Operate by Paid Release